Senior insider sale
Chief Commercial Officer at TARSUS PHARMACEUTICALS, INC. — senior position signals high conviction
$595.0K
8.62K shares
What this filing means
MOTTIWALA AZIZ plans to sell 8.62K shares of TARSUS PHARMACEUTICALS, INC. valued at approximately $595.0K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 3/18/2026ACC: 0001959173-26-002482
Officer· Chief Commercial Officer
Since Oct 2020
8.62K
Shares to sell
$595.0K
Approx. market value
4.33K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
Compensation
3/17/2026
4.33KTotal acquired4.33K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
3/17/2026 | Restricted Stock Vesting Compensation | 4.33K | — |
| Total | 4.33K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
4.29K
Market value
$297.5K
3/17/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
4.33K
Market value
$297.5K
3/18/2026
Total
Units
8.62K
Value
$595.0K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
3/17/2026 | 4.29K | $297.5K | — | Completed |
| Planned — Approximate Date | ||||
3/18/2026 | 4.33K | $297.5K | NASDAQ | Planned |
| Total | 8.62K | $595.0K | ||